ProAssurance Corp 最大收入來源為 T Cell Receptor-engineered T Cell,在最近的收益報告中收入為 2,816,000。就地區而言,United States 是 ProAssurance Corp 的主要市場,收入為 2,816,000。
ProAssurance Corp 是否盈利?
是的,根據最新的財務報表,ProAssurance Corp 的淨利潤為 $50
ProAssurance Corp 有負債嗎?
是的,ProAssurance Corp 的負債為 4,098
ProAssurance Corp 的流通股有多少?
ProAssurance Corp 的總流通股為 51.41
關鍵數據
前收市價
$24.7
開盤價
$24.69
當日範圍
$24.58 - $24.7
52週區間
$22.72 - $24.85
交易量
800.1K
平均成交量
620.1K
股息收益率
0.00%
每股盈餘 (TTM)
0.98
市值
$1.2B
什麼是 PRA?
ProAssurance Corp. is a holding company that engages in specialty insurance, providing medical professional liability, product liability for medical technology and life sciences. The company is headquartered in Birmingham, Alabama and currently employs 972 full-time employees. The firm's segments include Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. The Specialty Property and Casualty (Specialty P&C) segment is focused on professional liability insurance and medical technology liability insurance. Professional liability insurance is offered to healthcare providers and institutions and, to a lesser extent, to attorneys and their firms. The Workers' Compensation Insurance segment offers workers' compensation products in approximately 19 states in the East, South and Midwest regions of the continental United States. The Segregated Portfolio Cell Reinsurance segment includes the results of SPCs at Inova Re and Eastern Re, the Company's Cayman Islands SPC operations.